Advanced Biomed Inc. Reports Director and Officer Changes

Ticker: ADVB · Form: 8-K · Filed: May 28, 2025 · CIK: 1941029

Advanced Biomed INC. 8-K Filing Summary
FieldDetail
CompanyAdvanced Biomed INC. (ADVB)
Form Type8-K
Filed DateMay 28, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

TL;DR

Advanced Biomed Inc. filed an 8-K detailing director/officer changes and compensation. Effective 5/23/25.

AI Summary

Advanced Biomed Inc. filed an 8-K on May 28, 2025, reporting changes effective May 23, 2025. The filing covers the departure and election of directors, appointment of officers, and compensatory arrangements. The company is incorporated in Nevada and its principal executive offices are located in Tainan City, Taiwan.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.

Risk Assessment

Risk Level: low — This filing reports routine corporate governance changes and does not indicate immediate financial distress or significant operational shifts.

Key Players & Entities

FAQ

What specific changes were made regarding directors and officers?

The filing indicates the departure of directors, election of directors, and appointment of certain officers, along with details on compensatory arrangements.

When were these changes effective?

The earliest event reported is dated May 23, 2025.

What is the company's state of incorporation?

Advanced Biomed Inc. is incorporated in Nevada.

Where are the company's principal executive offices located?

The principal executive offices are located at No. 689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan.

What is the filing date of this Current Report?

This Current Report (Form 8-K) was filed on May 28, 2025.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Advanced Biomed Inc. (ADVB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing